Two-stage marker-stratified clinical trial design in the presence of biomarker misclassification

DOI10.1111/RSSC.12140MaRDI QIDQ6639143

Ying Yuan, Author name not available (Why is that?), Y. Zang

Publication date: 14 November 2024

Published in: Journal of the Royal Statistical Society. Series C. Applied Statistics (Search for Journal in Brave)

zbMATH Keywords

clinical trialexpectation-maximization algorithmpersonalized medicinemisclassificationmolecularly targeted agentmarker-stratified design

Mathematics Subject Classification ID

Applications of statistics (62Pxx)

Related Items (2)

Two-stage stratified designs with survival outcomes and adjustment for misclassification in predictive biomarkers ⋮ A Bayesian adaptive marker-stratified design for molecularly targeted agents with customized hierarchical modeling

This page was built for publication: Two-stage marker-stratified clinical trial design in the presence of biomarker misclassification

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6639143)